Erin Linnenbringer

Erin Linnenbringer, MS, PhD

Instructor in Surgery

Graduate School

Ph.D., Health Behavior and Health Education, University of Michigan School of Public Health, 2014

M.S., Genetic Counseling, Northwestern University Feinberg School of Medicine, 2003

Board Certifications

2005; 2015 - American Board of Genetic Counseling

Honors and Awards

2009-2013 - University of Michigan Population Studies Center Predoctoral Fellowship

2010 - Richard Janz Memorial Fund Award

2000-2001 - NIH Post-Baccalaureate Intramural Research Training Award Fellowship

1997-2000 - Washington University in St. Louis Arts & Sciences Scholar

Research Interests

Dr. Linnenbringer is a social demographer and board-certified genetic counselor. Broadly defined, her research explores the complex interplay among social, behavioral, and genetic factors, and their subsequent implications for population health and health disparities.  Dr. Linnenbringer is also developing new lines of research that will examine the impact of emerging precision medicine approaches on the health and well-being of medically underserved populations.

Grants & Projects
National Cancer Institute 
K07 CA212032
Integration of Genomic and Social Science in Breast Cancer Disparities Research
The objectives of this career development award are to 1) investigate potential interplay among state-level inequalities (defined by race, gender, and/or socioeconomic status), health behaviors, and genomic markers associated with estrogen receptor negative (ER-) breast cancer, and 2) complete advanced training in breast cancer genetic and molecular epidemiology
Role: Principal Investigator

National Cancer Institute
P20 CA192966-01A1 (PI: Graham Colditz)
Disparities of Health Literacy in the Context of Kidney Cancer and Smoking
Part of a feasibility study to build research collaborations between Siteman Cancer Center and Simmons Cancer Institute at Southern Illinois University, this pilot project evaluates health literacy, kidney cancer risk factor knowledge, and thresholds for urological symptom bother in rural and urban populations.
Role: Co-Principal Investigator (pilot project)

Contact Information

660 S. Euclid Ave.
Campus Box 8100
St. Louis, MO 63110
(314) 747-1966

Selected Publications

Select Peer-Reviewed Publications:

Geronimus AT, Pearson JA, Linnenbringer E, Schulz AJ, Reyes AG, Epel ES, Lin J, Blackburn EH. Race-Ethnicity, Poverty, Urban Stressors, and Telomere Length in a Detroit Community-based Sample. Journal of Health and Social Behavior. 2015 Apr 30. pii: 0022146515582100. [Epub ahead of print] PMID: 25930147

Christensen KD, Roberts JS, Zikmund-Fisher BJ, Kardia SL, McBride CM, Linnenbringer E, Green RC; REVEAL Study Group. Associations between self-referral and health behavior responses to genetic risk information. Genome Medicine. 2015 Jan 31;7(1):10. doi: 10.1186/s13073-014-0124-0. PMID: 25642295

Green RC, Christensen KD, Cupples LA, Relkin NR, Whitehouse PJ, Royal CD, Obisesan TO, Cook-Deegan R, Linnenbringer E, Butson MB, Fasaye G, Levinson E, Roberts JS; REVEAL Study Group. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease. Alzheimer’s & Dementia. 2014 Dec 9. pii: S1552-5260(14)02870-2. doi: 10.1016/j.jalz.2014.10.014. [Epub ahead of print] PMID: 25499536

Akinleye D, Roberts JS, Royal CDM, Linnenbringer E, Obisesan T, Fasaye G, Green RC. Differences between African American and white research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer’s disease. Journal of Genetic Counseling. 2011 Dec;20(6):650-9

Linnenbringer E, Roberts JS, Hiraki S, Cupples A, Green RC. “I know what you told me, but this is what I think”: perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate. Genetics in Medicine, 2010; 12(4):219-27

Cassidy MR, Roberts JS, Bird TD, Steinbart EJ, Cupples LA, Chen CA, Linnenbringer E, Green RC. Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer’s disease. Alzheimer's and Dementia, 2008; 4(6):406-13

Christensen KD, Roberts JS, Royal CDM, Fasaye G, Obisesan T, Cupples LA, Whitehouse PJ, Butson MB, Linnenbringer E, Relkin NR, Farrer L, Cook-Deegan R, Green RC. Incorporating ethnicity into genetic risk assessment for Alzheimer’s disease: The REVEAL Study experience. Genetics in Medicine, 2008; 10(3):207-214

Gooding HC, Linnenbringer E, Burack J, Roberts JS, Green RC, Biesecker BB. Genetic susceptibility testing for Alzheimer disease: Perceived threat and the search for information and control. Patient Education and Counseling, 2006; 64(1-3):259-67

LaRusse S, Roberts JS, Marteau TM, Katzen H, Linnenbringer E, Barber M, Whitehouse P, Quaide K, Green RC, Relkin N.  Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer's disease. Genetics in Medicine. 2005; 7(1):48-53

Dr. Linnenbringer on PubMed

Editorial Positions

Ad Hoc Reviewer:

2015, Psychoneuroendocrinology

2013, Contemporary Clinical Trials

2013, Alzheimer’s Research and Therapy

2006, American Journal of Medical Genetics, Part C: Seminars in Medical Genetics